Sørensen, Daniel Madriz http://orcid.org/0000-0001-8811-2506
Büll, Christian
Madsen, Thomas D. http://orcid.org/0000-0002-7598-4636
Lira-Navarrete, Erandi
Clausen, Thomas Mandel
Clark, Alex E. http://orcid.org/0000-0003-1687-416X
Garretson, Aaron F.
Karlsson, Richard http://orcid.org/0000-0003-0448-6135
Pijnenborg, Johan F. A. http://orcid.org/0000-0003-3668-2034
Yin, Xin
Miller, Rebecca L. http://orcid.org/0000-0001-8574-1948
Chanda, Sumit K.
Boltje, Thomas J.
Schjoldager, Katrine T. http://orcid.org/0000-0002-8592-6763
Vakhrushev, Sergey Y. http://orcid.org/0000-0002-0418-5765
Halim, Adnan
Esko, Jeffrey D.
Carlin, Aaron F. http://orcid.org/0000-0002-1669-8066
Hurtado-Guerrero, Ramon http://orcid.org/0000-0002-3122-9401
Weigert, Roberto http://orcid.org/0000-0003-0740-4465
Clausen, Henrik http://orcid.org/0000-0002-0915-5055
Narimatsu, Yoshiki http://orcid.org/0000-0003-1428-5695
Funding for this research was provided by:
Danmarks Grundforskningsfond (DNRF107)
Article History
Received: 24 October 2022
Accepted: 8 February 2023
First Online: 20 February 2023
Competing interests
: University of Copenhagen has filed a patent application covering the design of the cell-based screening assay for inhibitors described here, which is currently pending. Application numbers are: EP3455635A1, PCT/EP2017/061385, USPTO 20190330601, the inventors are: Eric Bennett, Yoshiki Narimatsu (Y.N.), Catharina Steentoft, Zhang Yang, Ulla Mandel, and Henrik Clausen (H.C.). GlycoDisplay Aps, Copenhagen, Denmark, has obtained a license to the field of the patent application. Y.N. and H.C. are co-founders of GlycoDisplay Aps and hold ownerships in the company as well as served as unpaid consultants. The remaining authors declare no competing interests.